Pioneering Nanopore Sequencing-Based COVID Diagnostic Bags Emergency Use Approval
By Rajaneesh K. Gopinath, Ph.D. Menlo Park, California-based Next-Generation Sequencing (NGS) company, Clear Labs, announced that its descriptive, diagnostic SARS-CoV-2 test (Clear Dx™ SARS-CoV-2) obtained the FDA’s emergency use authorization …
Read More